A Multi-centre, double blind, randomized placebo controlled phase II study to assess the efficacy and safety of ASCT01 in Critical limb Ischemia Patients - SCILI - SCILI
100 项与 XCell-Center GmbH 相关的临床结果
0 项与 XCell-Center GmbH 相关的专利(医药)
100 项与 XCell-Center GmbH 相关的药物交易
100 项与 XCell-Center GmbH 相关的转化医学